Warning: The NCBI web site requires JavaScript to function. more...
NSC109268 potentiates cisplatin-induced cell death in a p53-independent manner.
Shankar E, Basu C, Adkins B, Siede W, Basu A.
J Mol Signal. 2010 May 10;5:4.
Related citations
Over-expression of PTEN sensitizes human ovarian cancer cells to cisplatin-induced apoptosis in a p53-dependent manner.
Yan X, Fraser M, Qiu Q, Tsang BK.
Gynecol Oncol. 2006 Aug;102(2):348-55. Epub 2006 Mar 20.
Ovarian cancer cisplatin-resistant cell lines: multiple changes including collateral sensitivity to Taxol.
Perego P, Romanelli S, Carenini N, Magnani I, Leone R, Bonetti A, Paolicchi A, Zunino F.
Ann Oncol. 1998 Apr;9(4):423-30.
Cisplatin alters nitric oxide synthase levels in human ovarian cancer cells: involvement in p53 regulation and cisplatin resistance.
Leung EL, Fraser M, Fiscus RR, Tsang BK.
Br J Cancer. 2008 Jun 3;98(11):1803-9. Epub 2008 May 27.
Enhancement of cisplatin sensitivity by NSC109268 in budding yeast and human cancer cells is associated with inhibition of S-phase progression.
Jain D, Patel N, Shelton M, Basu A, Roque R, Siede W.
Cancer Chemother Pharmacol. 2010 Oct;66(5):945-52. Epub 2010 Jan 26.
Sensitization of p53-mutated epithelial ovarian cancer to CD95-mediated apoptosis is synergistically induced by cisplatin pretreatment.
Bagnoli M, Balladore E, Luison E, Alberti P, Raspagliesi F, Marcomini B, Canevari S, Mezzanzanica D.
Mol Cancer Ther. 2007 Feb;6(2):762-72.
Disruption of the MDM2-p53 interaction strongly potentiates p53-dependent apoptosis in cisplatin-resistant human testicular carcinoma cells via the Fas/FasL pathway.
Koster R, Timmer-Bosscha H, Bischoff R, Gietema JA, de Jong S.
Cell Death Dis. 2011 Apr 21;2:e148.
Oncolytic herpes simplex virus-1 lacking ICP34.5 induces p53-independent death and is efficacious against chemotherapy-resistant ovarian cancer.
Coukos G, Makrigiannakis A, Kang EH, Rubin SC, Albelda SM, Molnar-Kimber KL.
Clin Cancer Res. 2000 Aug;6(8):3342-53.
Human bladder cancer cells undergo cisplatin-induced apoptosis that is associated with p53-dependent and p53-independent responses.
Konstantakou EG, Voutsinas GE, Karkoulis PK, Aravantinos G, Margaritis LH, Stravopodis DJ.
Int J Oncol. 2009 Aug;35(2):401-16.
Akt promotes cisplatin resistance in human ovarian cancer cells through inhibition of p53 phosphorylation and nuclear function.
Fraser M, Bai T, Tsang BK.
Int J Cancer. 2008 Feb 1;122(3):534-46.
Cisplatin-mediated sensitivity to TRAIL-induced cell death in human granulosa tumor cells.
Woods DC, Alvarez C, Johnson AL.
Gynecol Oncol. 2008 Mar;108(3):632-40. Epub 2008 Jan 14.
Overexpression of HIPK2 circumvents the blockade of apoptosis in chemoresistant ovarian cancer cells.
Puca R, Nardinocchi L, Pistritto G, D'Orazi G.
Gynecol Oncol. 2008 Jun;109(3):403-10. Epub 2008 Apr 18.
[Relationship between the Akt-regulated direct p53 mitochondrial translocation and the resistance to cisplatin of ovarian cancer cells].
Zhou Y, Wang SY, Yang XK, Wang HM.
Zhonghua Zhong Liu Za Zhi. 2011 Feb;33(2):97-100. Chinese.
Status of p53 phosphorylation and function in sensitive and resistant human cancer models exposed to platinum-based DNA damaging agents.
Mujoo K, Watanabe M, Nakamura J, Khokhar AR, Siddik ZH.
J Cancer Res Clin Oncol. 2003 Dec;129(12):709-18. Epub 2003 Sep 26.
Final Report on Carcinogens Background Document for Formaldehyde.
National Toxicology Program.
Rep Carcinog Backgr Doc. 2010 Jan;(10-5981):i-512.
Time-dependent changes in factors involved in the apoptotic process in human ovarian cancer cells as a response to cisplatin.
Kolfschoten GM, Hulscher TM, Schrier SM, van Houten VM, Pinedo HM, Boven E.
Gynecol Oncol. 2002 Mar;84(3):404-12.
Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems.
Perego P, Giarola M, Righetti SC, Supino R, Caserini C, Delia D, Pierotti MA, Miyashita T, Reed JC, Zunino F.
Cancer Res. 1996 Feb 1;56(3):556-62.
Human melanoma cells selected for resistance to apoptosis by prolonged exposure to tumor necrosis factor-related apoptosis-inducing ligand are more vulnerable to necrotic cell death induced by cisplatin.
Zhang XD, Wu JJ, Gillespie S, Borrow J, Hersey P.
Clin Cancer Res. 2006 Feb 15;12(4):1355-64.
Expression of p53 in cisplatin-resistant ovarian cancer cell lines: modulation with the novel platinum analogue (1R, 2R-diaminocyclohexane)(trans-diacetato)(dichloro)-platinum(IV).
Hagopian GS, Mills GB, Khokhar AR, Bast RC Jr, Siddik ZH.
Clin Cancer Res. 1999 Mar;5(3):655-63.
Knockdown of CITED2 using short-hairpin RNA sensitizes cancer cells to cisplatin through stabilization of p53 and enhancement of p53-dependent apoptosis.
Wu ZZ, Sun NK, Chao CC.
J Cell Physiol. 2011 Sep;226(9):2415-28. doi: 10.1002/jcp.22589.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on